Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1997;80:295-296

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, R. A.
(Circulation Research. 1997;80:295-296.)
© 1997 American Heart Association, Inc.


Articles

Microtubules and Pressure-Overload Hypertrophy

Richard A. Walsh

Correspondence to Richard A. Walsh, MD, Director of Cardiology & Cardiovascular Center, University of Cincinnati College of Medicine, PO Box 670542, Cincinnati, OH 45267-0542 E-mail WALSHRA@UCBEH.SAN.UC.EDU


Key Words: cardiomyocyte • cytoskeleton • hypertrophy


*    Introduction
 
Cardiac hypertrophy is a process whereby an increase in chamber mass occurs largely by an increase in size of terminally differentiated cardiomyocytes in response to increased external and/or internal work. Hypertrophied cardiomyocytes have abnormal electrical and mechanical properties that underlie, at least in part, altered cardiovascular function in a variety of pathological states. In particular, heart failure of diverse origins is invariably accompanied by hypertrophy, and contractile failure appears to be an inevitable consequence of hypertrophic stimuli of sufficient severity and duration. Molecular and biochemical mechanisms that are responsible for functions of the hypertrophied cardiomyocyte are being intensively studied using genetically engineered mice, animal models of human disease, and clinical investigations. These approaches have identified important alterations in myofilament and calcium-cycling proteins, sarcolemmal ion pumps, channels, and receptors and in various signal transduction pathways of hypertrophied hearts.1

In contrast to our knowledge of the importance of alterations in proteins that actively participate in myocyte contraction, relaxation, and growth, there is less information regarding the role of cytoarchitectural components of the cardiomyocyte in normal and pathological states. The cardiomyocyte cytoskeleton is composed of myofibrillar and extramyofibrillar or cytoplasmic compartments. Biophysical interactions among sarcolemmal integrin receptors and the cytoplasmic and myofibrillar cytoskeleton are largely unknown. The myofibrillar cytoskeleton includes titin (the largest protein known and the third most abundant cardiac protein), desmin, C protein, nebulin, and vinculin.2 The extramyofibrillar cytoskeleton of all eukaryotic cells, including the cardiomyocyte, is composed of an intertwined network of three classes of filamentous biopolymers: actin-containing microfilaments, intermediate . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. A. Schroder, K. Tobita, J. P. Tinney, J. K. Foldes, and B. B. Keller
Microtubule Involvement in the Adaptation to Altered Mechanical Load in Developing Chick Myocardium
Circ. Res., August 23, 2002; 91(4): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Koide, M. Hamawaki, T. Narishige, H. Sato, S. Nemoto, G. DeFreyte, M. R. Zile, G. Cooper IV, and B. A. Carabello
Microtubule Depolymerization Normalizes In Vivo Myocardial Contractile Function in Dogs With Pressure-Overload Left Ventricular Hypertrophy
Circulation, August 29, 2000; 102(9): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Webster and D. L. Patrick
Beating rate of isolated neonatal cardiomyocytes is regulated by the stable microtubule subset
Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1653 - H1661.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Hein, S. Kostin, A. Heling, Y. Maeno, and J. Schaper
The role of the cytoskeleton in heart failure
Cardiovasc Res, January 14, 2000; 45(2): 273 - 278.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Walsh
Calcineurin Inhibition as Therapy for Cardiac Hypertrophy and Heart Failure : Requiescat in Pace?
Circ. Res., April 2, 1999; 84(6): 741 - 743.
[Full Text] [PDF]


Home page
HypertensionHome page
A. C. Cicogna, K. G. Robinson, C. H. Conrad, K. Singh, R. Squire, M. P. Okoshi, and O. H. L. Bing
Direct Effects of Colchicine on Myocardial Function : Studies in Hypertrophied and Failing Spontaneously Hypertensive Rats
Hypertension, January 1, 1999; 33(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Tagawa, M. Koide, H. Sato, M. R. Zile, B. A. Carabello, and G. Cooper IV
Cytoskeletal Role in the Transition From Compensated to Decompensated Hypertrophy During Adult Canine Left Ventricular Pressure Overloading
Circ. Res., April 20, 1998; 82(7): 751 - 761.
[Abstract] [Full Text] [PDF]